Cohort validation pack
AESOP
Aetiology and Ethnicity in Schizophrenia and Other Psychoses
Generated 6 Oct 2026, 10:36 · ID 59
Last verified: 16/04/2026
Instructions for reviewers
- Review each field against your knowledge of this cohort. Mark Accurate if the value is right, Needs correction if it is wrong or inaccurate (add notes), Not sure if you cannot verify it, or Does not apply if the field is not relevant.
- Evidence shown is from our source registry. Fields marked No source yet hold values we could not yet pin to a document — those were AI-inferred and need your input most. Fields marked Searched — not published are ones we looked for and could not find publicly; the note lists where we checked.
- Your selections and notes are kept in this browser tab only (not sent to the database). Print or save as PDF when finished, then return it to the DIGIT team.
Overview
75
Total fields
49
Field-cited
0
Whole-record source only
6
AI-inferred, no source yet
15
Searched — not published
19
No value held
21
Needs review
Source coverage
Summary of how well fields in this pack are linked to evidence.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Field-level source coverage Optional | 49 of 70 reviewable fields are cited to a source (70%) · 6 with no source yet · 15 searched — not published · 19 with no value held | Computed | No citation linked to this field yet. | No response selected | No notes |
Identity and ownership
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Short name Required | AESOP | Field-cited |
| No response selected | No notes |
Full name Required | Aetiology and Ethnicity in Schizophrenia and Other Psychoses | Field-cited |
| No response selected | No notes |
Managing organisation Recommended | King's College London / University of Nottingham / University of Bristol | Field-cited |
| No response selected | No notes |
Primary site Recommended | NIHR Maudsley Biomedical Research Centre (site #1) | Field-cited |
| No response selected | No notes |
Website URL Recommended | No value held | Not published |
| No response selected | No notes |
Catalogue of Mental Health Measures URL Recommended | https://www.cataloguementalhealth.ac.uk/AESOP-10 | Field-cited |
| No response selected | No notes |
Contact name Recommended | No value held | Not published |
| No response selected | No notes |
Contact email Recommended | No value held | Not published |
| No response selected | No notes |
Summary and status
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Description Required | Multi-ethnic first-episode psychosis incidence study across three UK centres (South London, Nottingham, Bristol). 568 FEP cases identified in defined catchment areas (Fearon et al. 2006). Detailed clinical and social assessments; MRI substudies in subsamples (e.g. Dazzan et al.). | Field-cited |
| No response selected | No notes |
Total N Required | 568 | Field-cited |
| No response selected | No notes |
Total N qualifier Recommended | cases | Field-cited |
| No response selected | No notes |
Year established Recommended | 1997 | Field-cited |
| No response selected | No notes |
Active cohort Recommended | No | Field-cited |
| No response selected | No notes |
Ongoing recruitment Recommended | No | Field-cited |
| No response selected | No notes |
Refreshed cohort Recommended | No | Field-cited |
| No response selected | No notes |
Recontact success rate Recommended | No value held | Not published |
| No response selected | No notes |
Retention rate Recommended | No value held | Not published |
| No response selected | No notes |
Published references Recommended | doi:10.1017/S0033291706008774, doi:10.1192/bjp.bp.106.021303 | Field-cited |
| No response selected | No notes |
Notes Recommended | Landmark UK multi-ethnic psychosis incidence study (568 first-onset cases). High IRRs for schizophrenia and manic psychosis in African-Caribbean and Black African groups vs White British (Fearon et al. 2006). 10-year AESOP-10 follow-up programme documents repeat MRI and neurocognition (KCL). | Field-cited |
| No response selected | No notes |
3D cohort mapping
Consent, characterisation, and data availability axes used on the cohort map.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Consent level (axis) Required | 3 — Broad consent (recontactable for future studies) | Field-cited |
| No response selected | No notes |
Characterisation depth (axis) Required | 3 — Multi-domain MH characterisation | Field-cited |
| No response selected | No notes |
Data availability (axis) Required | 2 — Records + research data | Field-cited |
| No response selected | No notes |
Cohort map group (derived) Recommended | Group 3 | Internal | Internal catalogue field | — | — |
Population type Recommended | Clinical | Not published |
| No response selected | No notes |
Industry engagement status Recommended | Unknown | Not published |
| No response selected | No notes |
Parent cohort / programme Recommended | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
TWiCs eligible Recommended | No | Field-cited |
| No response selected | No notes |
Data modalities
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Questionnaire / interview Recommended | Yes | Field-cited |
| No response selected | No notes |
Cognitive testing Recommended | Yes | Field-cited |
| No response selected | No notes |
Physical measures Recommended | Yes | Field-cited |
| No response selected | No notes |
Biosamples Recommended | No | Field-cited |
| No response selected | No notes |
Genomic data Recommended | No | Field-cited |
| No response selected | No notes |
Omics Recommended | No | Field-cited |
| No response selected | No notes |
Imaging Recommended | Yes | Field-cited |
| No response selected | No notes |
Wearable / sensor Recommended | No | Field-cited |
| No response selected | No notes |
Digital phenotyping Recommended | No | Field-cited |
| No response selected | No notes |
Linked health records Recommended | No | Field-cited |
| No response selected | No notes |
Biosample types Recommended | No value held | Not published |
| No response selected | No notes |
Genotyping platform Recommended | No value held | Not published |
| No response selected | No notes |
Imaging modalities Recommended | MRI | Field-cited |
| No response selected | No notes |
Mental health measures Recommended | SCAN, PANSS, GAF, SFS | Field-cited |
| No response selected | No notes |
Data subcategories
Structured modality and subcategory rows used alongside the high-level data-type flags.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Data subcategories Recommended List key data subcategories using distinct rows for category markers, named questionnaire/interview instruments, biospecimen types, omics/genomics data products, imaging modalities, sensor streams, and linked-record types. | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
Consent and use permissions
Specific use permissions separate from the 3D consent-level axis.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Consent and use permissions Recommended Confirm health/biomedical research use, industry/commercial consideration, non-commercial restrictions, governance modifiers, recontact, trial approach, biosample use, linkage, sharing, international transfer, and any Section 251/CAG support. | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
Access pathways
One or more routes by which researchers can request or analyse data.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Access pathways Recommended Confirm all data access pathways, including route, access level, TRE/SDE or download/API environment, DAC review, collaboration requirements, data sharing agreements, output checking, timelines, and fees. | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
Within-cohort coverage
Aggregate counts or percentages showing how broadly data, consent, or access characteristics apply within the cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Within-cohort coverage metrics Recommended Provide numerator, denominator, unit type, numerator/denominator exactness qualifiers, denominator type, basis, date/release, original source wording, and whether each metric is marginal, joint, conditional, or a release total. | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
Linkage and access
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
NHS linkage Recommended | No | Field-cited |
| No response selected | No notes |
GP linkage Recommended | No | Field-cited |
| No response selected | No notes |
Death registry linkage Recommended | No | Field-cited |
| No response selected | No notes |
Education linkage Recommended | No | Field-cited |
| No response selected | No notes |
Data access mechanism Recommended | No value held | Not published |
| No response selected | No notes |
TRE platform Recommended | No value held | Not published |
| No response selected | No notes |
Data dictionary URL Recommended | No value held | Not published |
| No response selected | No notes |
Data access timeline (days) Recommended | No value held | Not published |
| No response selected | No notes |
Data access cost Recommended | No value held | Not published |
| No response selected | No notes |
Participant profile and dates
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Age distribution Recommended | 16-35: 0.75; 36-65: 0.25 | Field-cited |
| No response selected | No notes |
Sex distribution Recommended | male: 0.63; female: 0.37 | Field-cited |
| No response selected | No notes |
Ethnicity distribution Recommended | other: 0.17; black_african: 0.14; white_british: 0.41; black_caribbean: 0.28 | Field-cited |
| No response selected | No notes |
Smoking status distribution Recommended | No value held | No source yet | No citation linked to this field yet. | No response selected | No notes |
Median age Recommended | No value held | Not published |
| No response selected | No notes |
Percent female Recommended | 37.00 | Field-cited |
| No response selected | No notes |
Percent non-white Recommended | 59.00 | Field-cited |
| No response selected | No notes |
Geographic coverage Recommended | multi_site | Field-cited |
| No response selected | No notes |
Follow-up duration Recommended | 10-year follow-up programme (AESOP-10) per KCL project page | Field-cited |
| No response selected | No notes |
Last data collection date Recommended | 31 Dec 2010 | Field-cited |
| No response selected | No notes |
Recruitment start date Recommended | 1 Jan 1997 | Field-cited |
| No response selected | No notes |
Recruitment end date Recommended | 31 Dec 2000 | Field-cited |
| No response selected | No notes |
Diagnosis areas
Mental health diagnosis areas represented in this cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Diagnosis area: Schizophrenia Recommended Confirm this diagnosis area applies and estimated N if shown. | Schizophrenia · Psychotic Disorders · est. n=178 | Field-cited |
| No response selected | No notes |
Diagnosis area: First-episode psychosis Recommended Confirm this diagnosis area applies and estimated N if shown. | First-episode psychosis · Psychotic Disorders · est. n=390 | Field-cited |
| No response selected | No notes |
Linked sites
Sites contributing participants or data to this cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Linked site: NIHR Nottingham Biomedical Research Centre Recommended | NIHR Nottingham Biomedical Research Centre · East Midlands | Field-cited |
| No response selected | No notes |
Linked site: NIHR Maudsley Biomedical Research Centre Recommended | NIHR Maudsley Biomedical Research Centre · London | Field-cited |
| No response selected | No notes |
Linked site: NIHR Bristol Biomedical Research Centre Recommended | NIHR Bristol Biomedical Research Centre · South West England | Field-cited |
| No response selected | No notes |
Verification metadata
Internal catalogue status — for reference only.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Verification status Recommended | unverified | Internal | Internal catalogue field | — | — |
Last verified Recommended | 16 Apr 2026 | Internal | Internal catalogue field | — | — |
Data source Recommended | Verified Apr 2026 from Fearon et al. 2006 Psychol Med (Europe PMC), Morgan et al. 2006 Br J Psychiatry (Cambridge PDF), KCL AESOP-10 page, Catalogue of Mental Health Measures (AESOP-10), ClinicalTrials.gov API v2 search, ISRCTN XML API search, HDR UK Innovation Gateway browse, DPUK/UKCRC cohort browser (no separate card) | Internal | Internal catalogue field | — | — |